$GTSIF / $LOBED - Lobe Sciences plans to advance to Phase 1 PTSD study in second half of 2022 with psilocybin and NAC #BIO #SCIENCE #BioTechnology #investors #otc #nasdaq #wallstreet #psychedelic #research
Lobe Sciences plans to advance to Phase 1 PTSD study in second half of 2022 with psilocybin and NAC - YouTube